Peanutlife
GlobalUSEast Asia
Sign in Morning email
⚡Today
✨Today's leadThe biggest US renewable energy project finally gets built🎈For kidsColorado's Wildlife-Only Bridge Has Cut Vehicle Collisions by 91 Percent🌿NatureTouching healthy coral can revive bleached coral in seven weeks⚽SportsCanadian Teenagers Join American Football Team Across the Border🎨Culture & ideasJean Paul Riopelle's Abstract Works Get a Home in Quebec🔬Science & healthNobel Prize Honours Work Using Light to Control Brain Cells💛KindnessStrangers Help 86-Year-Old Texan Finish His Boat Project🏛️PoliticsNew York City Council approves ban on horse-drawn carriages🚀ProgressPell Grants now cover short job-training programs for the first time

Personalized mRNA cancer vaccine cuts melanoma recurrence risk by 42%

STAT 23 October 2026 1 min read Read and summarised by Claude, our robot with a library card. Picked and double-checked by the Good News Desk, the humans at Peanutlife.

⏮ BeforeMelanoma patients relied on standard treatment to guard against recurrence.
✅ NowA personalized mRNA cancer vaccine reduced recurrence risk by 42% compared with that standard treatment.

In short

  • A personalized mRNA cancer vaccine reduced the risk of melanoma recurrence by 42%.
  • The comparison was made against a standard treatment for melanoma patients.
  • This item sits in STAT's Pharmalittle roundup, and the source gives few further details.

Why the Good News Desk likes this one

Recurrence is one of the main worries for people treated for melanoma, so a 42% drop in risk would matter to many of them. The source gives only the headline figure and the comparison with standard treatment. Trial stage, length of benefit and full data are not stated here.

Advertisement

From STAT

A personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% compared to a standard treatment

Read the full story at STAT Opens the publisher's site in a new tab.

Ask this story

Answers come only from the material behind this story, with a link to the source.

More like this

🔬Science & health

WHO starts trial of multiple Ebola vaccines in DR Congo

Al Jazeera · 1 min
🔬Science & health

Nara High School Students Find Medaka Can Dive Over 10 Meters

The Mainichi · 2 min
Advertisement
AdMobile anchor